Sleep apnea machine tested for IPF lung health – but study stopped early
NCT ID NCT05359965
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether using a CPAP machine at night could reduce abnormal acid reflux and lung inflammation in people with idiopathic pulmonary fibrosis (IPF) who also have sleep apnea. Only 7 people enrolled before the study was terminated early. The goal was to measure changes in certain lung inflammation markers and acid levels in the esophagus.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Continuous Positive Airway Pressure (CPAP) device
- What this could lead to
- If it had succeeded, this could have pointed toward a way to manage reflux and lung inflammation in IPF patients with sleep apnea.
- What could go wrong
- The study was terminated early with only 7 participants, so results are very limited. It is too small and incomplete to draw any conclusions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO ESOPHAGEAL REFLUX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Arizona
Tucson, Arizona, 85724, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do current sleepiness tests work for kids? a new study puts them to the test
- Remote monitoring may boost sleep apnea therapy adherence
- Could a mouthpiece replace the CPAP machine for sleep apnea?
- Can a new painkiller prevent breathing crises after surgery?
- Can a new pill slow lung scarring in IPF?
- Beyond the lungs: the hidden emotional toll of IPF medications